These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36246663)

  • 1. Comprehensive analysis of m
    Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Liu L; Jiang T
    Front Genet; 2022; 13():996950. PubMed ID: 36246663
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-omics analysis of m
    Wu X; Bai Z
    Sci Rep; 2021 Oct; 11(1):20921. PubMed ID: 34686691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M
    Chen H; Ge XL; Zhang ZY; Liu M; Wu RY; Zhang XF; Xu LP; Cheng HY; Sun XC; Zhu HC
    Transl Lung Cancer Res; 2021 May; 10(5):2172-2192. PubMed ID: 34164268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer.
    Yang Q; Xu F; Jian A; Yu H; Ye T; Hu W
    Front Cell Dev Biol; 2021; 9():803141. PubMed ID: 35198565
    [No Abstract]   [Full Text] [Related]  

  • 6. m
    Chong W; Shang L; Liu J; Fang Z; Du F; Wu H; Liu Y; Wang Z; Chen Y; Jia S; Chen L; Li L; Chen H
    Theranostics; 2021; 11(5):2201-2217. PubMed ID: 33500720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
    Ye W; Huang T
    PLoS One; 2022; 17(2):e0264384. PubMed ID: 35196365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma.
    He W; Lin G; Pan C; Li W; Shen J; Liu Y; Li H; Wu D; Lin X
    Front Genet; 2022; 13():761681. PubMed ID: 35154267
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of m
    Zhu M; Cui Y; Mo Q; Zhang J; Zhao T; Xu Y; Wu Z; Sun D; Zhang X; Li Y; You Q
    Front Immunol; 2021; 12():782551. PubMed ID: 34975871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Wang L; Hu X; Liu X; Feng Y; Zhang Y; Han J; Liu X; Meng F
    Front Immunol; 2022; 13():1022720. PubMed ID: 36389726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation Pattern Mediated by m
    Jiang F; Hu Y; Liu X; Wang M; Wu C
    Oxid Med Cell Longev; 2022; 2022():2930310. PubMed ID: 35035657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Yu L; Ji T; Liao W; Xu Y; Fang Y; Zhu Q; Nie J; Yang D
    Clin Epigenetics; 2023 Mar; 15(1):43. PubMed ID: 36932439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer.
    Chen Z; Li Q; Lin Y; Lin S; Gao J; Chen S
    Sci Rep; 2023 Jul; 13(1):11950. PubMed ID: 37488178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
    Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
    Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.
    Maimaiti A; Feng Z; Liu Y; Turhon M; Xie Z; Baihetiyaer Y; Wang X; Kasimu M; Jiang L; Wang Y; Wang Z; Pei Y
    Eur J Med Res; 2023 Mar; 28(1):144. PubMed ID: 36998056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of N6-Methyladenosine (m
    Liu D; Yuan M; Wang Z; Sun L; Fang Y; Ma X; Zhang L; Xing Y; Zhu J; Liu Y; Zhu W; Bao S; Jia Y; Wang Y
    Can J Gastroenterol Hepatol; 2022; 2022():3506518. PubMed ID: 36452120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA m
    Zhang Q; Sun X; Sun J; Lu J; Gao X; Shen K; Qin X
    Front Immunol; 2022; 13():905057. PubMed ID: 36389669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of m
    Pei D; Xu C; Wang D; Shi X; Zhang Y; Liu Y; Liu N; Guo J; Yu Y; Kang Z; Zhu H
    J Oncol; 2022; 2022():2910491. PubMed ID: 35281520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers.
    He CM; Zhang XD; Zhu SX; Zheng JJ; Wang YM; Wang Q; Yin H; Fu YJ; Xue S; Tang J; Zhao XJ
    Front Genet; 2022; 13():998147. PubMed ID: 36226166
    [No Abstract]   [Full Text] [Related]  

  • 20. m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma.
    Liu Z; He J; Han J; Yang J; Liao W; Chen N
    Front Immunol; 2021; 12():762243. PubMed ID: 35069534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.